의존증 치료 시장 규모, 점유율, 성장 분석 : 유형별, 약제 유형별, 치료 시설별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Addiction Treatment Market size was valued at USD 5.71 Billion in 2024 and is poised to grow from USD 6.04 Billion in 2025 to USD 9.49 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The addiction treatment market is experiencing significant growth driven by heightened awareness of available treatments and the escalating prevalence of addiction issues. Government initiatives, including drug awareness campaigns and prevention programs, are further supporting this market expansion. Addiction often arises from the excessive use of illegal substances, prescription medications, or alcohol. To alleviate symptoms and manage cravings associated with substance use disorders, a variety of medications such as methadone, buprenorphine, naltrexone, and disulfiram are utilized. Treatment approaches also incorporate behavioral therapies like family therapy, motivational interviewing, and cognitive behavioral therapy (CBT). The integration of telemedicine, digital health technologies, and mobile applications is broadening treatment opportunities and improving efficiency, while increased insurance coverage enhances service accessibility, promoting overall market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Addiction Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Addiction Treatment Market Segments Analysis

Global Addiction Treatment Market is segmented by Type, Drug Type, Treatment Centers, Distribution Channel, and region. Based on Type, the market is segmented into Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, and Others. Based on Drug Type, the market is segmented into Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, Others. Based on Treatment Centers, the market is segmented into Residential Treatment Centers, Outpatient Treatment Centers, and Inpatient Treatment Centers. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Addiction Treatment Market

One of the key market drivers for the Global Addiction Treatment Market is the increasing prevalence of substance use disorders and behavioral addictions. The rising incidences of opioid dependence, alcohol-related issues, and co-occurring mental health disorders necessitate comprehensive treatment solutions. Growing awareness regarding the importance of mental health and addiction recovery is prompting governments and healthcare organizations to invest in specialized treatment programs. Additionally, advancements in therapeutic approaches and the integration of technology for better patient monitoring and support further contribute to the demand for effective addiction treatment services, driving market growth and innovation in this essential healthcare sector.

Restraints in the Addiction Treatment Market

One key market restraint for the global addiction treatment market is the stigma associated with substance use disorders and treatment seeking. Individuals struggling with addiction may experience social stigma that discourages them from pursuing help, thereby limiting the pool of potential patients for treatment facilities. Furthermore, this stigma can also affect healthcare professionals, leading to biases in the provision of care, ultimately resulting in inadequate treatment options. The lack of public awareness and understanding of addiction as a medical condition hampers efforts to integrate effective treatment solutions, which can hinder market growth and limit accessibility to essential resources for those in need.

Market Trends of the Addiction Treatment Market

The addiction treatment market is experiencing a transformative shift driven by the rise of digital health solutions. The integration of telehealth platforms has revolutionized access to care, allowing patients to engage in consultations, therapy, and follow-ups from the comfort of their homes. This technological advancement not only facilitates greater access to treatment but also empowers both healthcare providers and patients with real-time monitoring of physiological markers related to stress and relapse risks. As digital tools continue to proliferate, they will enhance individualized care, minimize stigma, and likely improve overall treatment outcomes, positioning the addiction treatment market for significant growth.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Case study Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Addiction Treatment Market by Type

• Market Overview
• Alcohol Addiction Treatment
• Tobacco/Nicotine Addiction Treatment
• Opioid Addiction Treatment
• Others

Addiction Treatment Market by Drug Type

• Market Overview
• Bupropion
• Varenicline
• Acamprosate
• Disulfiram
• Naltrexone
• Methadone
• Buprenorphine
• Nicotine Replacement Products
• Others

Addiction Treatment Market by Treatment Centers

• Market Overview
• Residential Treatment Centers
• Outpatient Treatment Centers
• Inpatient Treatment Centers

Addiction Treatment Market by Distribution Channel

• Market Overview
• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

Addiction Treatment Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Alkermes plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indivior PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orexo AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pear Therapeutics (US) Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Addiction Centers, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sage Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acadia Pharmaceuticals Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medications for Addiction Treatment (MAT) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intra-Cellular Therapies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hims & Hers Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lundbeck A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caron Treatment Centers (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smart Recovery (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recovery Brands (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments